Cytosorbents Corp
CTSO
59 hedge funds and large institutions have $51.3M invested in Cytosorbents Corp in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.
500% more call options, than puts
Call options by funds: $186K | Put options by funds: $31K
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
127% more capital invested
Capital invested by funds: $22.6M → $51.3M (+$28.8M)
13% more funds holding
Funds holding: 52 → 59 (+7)
1.47% more ownership
Funds ownership: 33.36% → 34.84% (+1.5%)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$703K |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$639K |
| 3 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$326K |
| 4 |
Jane Street
New York
|
+$187K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$254K |
| 2 |
E
Ergoteles
New York
|
-$231K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$78.5K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$75K |
| 5 |
Millennium Management
New York
|
-$68.9K |
CTSO Hedge Fund Activity: Q1 2023 in Review
59 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2023, worth a combined $51.3M — up 127% from $22.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CTSO positions and 2 closed out — a net gain of 7 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was Sargent Investment Group, adding an estimated $703K. The largest seller was Redmile Group, cutting an estimated $254K.
- 59 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2023, up from 52 in Q4 2022.
- Funds reported $51.3M of Cytosorbents Corp stock for Q1 2023, up 127% quarter-over-quarter.
- 9 funds opened new Cytosorbents Corp positions in Q1 2023 and 2 closed out, a net change of +7 holders.
- The largest Cytosorbents Corp buyer in Q1 2023 was Sargent Investment Group, an estimated $703K added.
- The largest Cytosorbents Corp seller in Q1 2023 was Redmile Group, an estimated $254K sold.
Based on aggregated 13F filings for Q1 2023.